gland pharma glp-1 capacity Market Overview: Agonists and the Obesity Market | Blog Gland Pharma Q4 profit slips,

ADD THE FIRST COMMENT If you are a health practitioner, you may Login/Register to comment

GLP-1s are known to reduce both fat and muscle mass and discontinuation typically results in weight regainprimarily as fat massresulting in a less healthy body composition compared to treatment initiation

Disclosures: MARAM ALENZI: Nothing to Disclose, Pinzhu Huang: Nothing to Disclose, Heansika Matta: Nothing to Disclose, Disha Badlani: Nothing to Disclose, David GUARDAMINO OJEDA: Nothing to Disclose, Gloria Horta: Nothing to Disclose, Michelle Lai: Nothing to Disclose, Z

Biochem Pharmacol 2023;213:115613.ArticlePubMedPMC 36

New Developments Drug companies are working on: Pills instead of shots Medicines that work even better Combinations with other drugs Lower-cost options As more options become available, youll have more choices for your care